{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:04:16Z","timestamp":1785787456831,"version":"3.56.0"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1097\/01.mol.0000137222.23784.2a","type":"journal-article","created":{"date-parts":[[2004,7,8]],"date-time":"2004-07-08T04:04:51Z","timestamp":1089259491000},"page":"413-422","source":"Crossref","is-referenced-by-count":75,"title":["Current management of severe homozygous hypercholesterolaemias"],"prefix":"10.1097","volume":"15","author":[{"given":"Rossi P","family":"Naoumova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert R","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K","family":"Soutar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archinte.1939.00190040016002","article-title":"Angina pectoris in hereditary xanthomatosis.","volume":"64","author":"Muller","year":"1939","journal-title":"Arch Intern Med"},{"key":"R2-7-20210205","first-page":"39","article-title":"The metabolic lesion in familial hypercholesterolaemia.","volume":"33","author":"Myant","year":"1977","journal-title":"Expos Annu Biochim Med"},{"key":"R3-7-20210205","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1016\/S0021-9258(19)42341-7","article-title":"Binding and degradation of low density lipoproteins by cultured human fibroblasts: comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.","volume":"249","author":"Goldstein","year":"1974","journal-title":"J Biol Chem"},{"key":"R4-7-20210205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.ge.13.120179.001355","article-title":"The LDL receptor locus and the genetics of familial hypercholesterolemia.","volume":"13","author":"Goldstein","year":"1979","journal-title":"Annu Rev Genet"},{"key":"R5-7-20210205","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI112729","article-title":"In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia.","volume":"78","author":"Vega","year":"1986","journal-title":"J Clin Invest"},{"key":"R6-7-20210205","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/01.ATV.11.3.691","article-title":"Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.","volume":"11","author":"Myant","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"R7-7-20210205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000175431","article-title":"Experiences with the homozygous cases of familial hypercholesterolemia: a report of 52 patients.","volume":"15","author":"Khachadurian","year":"1973","journal-title":"Nutr Metab"},{"key":"R8-7-20210205","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","article-title":"Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein.","volume":"292","author":"Garcia","year":"2001","journal-title":"Science"},{"key":"R9-7-20210205","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1172\/JCI0216445","article-title":"Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1.","volume":"110","author":"Eden","year":"2002","journal-title":"J Clin Invest"},{"key":"R10-7-20210205","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-2275(20)41411-7","article-title":"Sitosterolemia.","volume":"33","author":"Salen","year":"1992","journal-title":"J Lipid Res"},{"key":"R11-7-20210205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.","volume":"110","author":"Pullinger","year":"2002","journal-title":"J Clin Invest"},{"key":"R12-7-20210205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"R13-7-20210205","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1073\/pnas.86.11.4166","article-title":"Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors.","volume":"86","author":"Soutar","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-7-20210205","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-2275(20)41433-6","article-title":"Characterization of two new point mutations in the low density lipoprotein receptor genes of an English patient with homozygous familial hypercholesterolemia.","volume":"33","author":"Webb","year":"1992","journal-title":"J Lipid Res"},{"key":"R15-7-20210205","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0022-2275(20)37623-9","article-title":"Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom.","volume":"37","author":"Webb","year":"1996","journal-title":"J Lipid Res"},{"key":"R16-7-20210205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0021-9150(93)90260-2","article-title":"Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia.","volume":"103","author":"Feher","year":"1993","journal-title":"Atherosclerosis"},{"key":"R17-7-20210205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1034\/j.1399-0004.1999.560308.x","article-title":"Inheritance of two different alleles of the low-density lipoprotein (LDL)-receptor gene carrying the recurrent Pro664Leu mutation in a patient with homozygous familial hypercholesterolaemia.","volume":"56","author":"Bourbon","year":"1999","journal-title":"Clin Genet"},{"key":"R20-7-20210205","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(03)14234-1","article-title":"Dyslipidaemia.","volume":"362","author":"Durrington","year":"2003","journal-title":"Lancet"},{"key":"R21-7-20210205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(93)90171-P","article-title":"Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.","volume":"104","author":"Myant","year":"1993","journal-title":"Atherosclerosis"},{"key":"R22-7-20210205","first-page":"370","article-title":"Familial defective apolipoprotein B-100.","volume":"45","author":"Hansen","year":"1998","journal-title":"Dan Med Bull"},{"key":"R23-7-20210205","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/01.ATV.0000094410.66558.9A","article-title":"Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia.","volume":"23","author":"Soutar","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R24-7-20210205","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI6677","article-title":"Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia.","volume":"104","author":"Norman","year":"1999","journal-title":"J Clin Invest"},{"key":"R25-7-20210205","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(02)07955-2","article-title":"Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis.","volume":"359","author":"Arca","year":"2002","journal-title":"Lancet"},{"key":"R26-7-20210205","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0021-9150(02)00379-9","article-title":"Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene.","volume":"166","author":"Barbagallo","year":"2003","journal-title":"Atherosclerosis"},{"key":"R27-7-20210205","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1210\/jc.2002-021487","article-title":"Clinical features and genetic analysis of autosomal recessive hypercholesterolemia.","volume":"88","author":"Harada-Shiba","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-7-20210205","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/01.RES.0000018002.43041.08","article-title":"Mutation in the ARH gene and a chromosome 13q locus influence cholesterol levels in a new form of digenic-recessive familial hypercholesterolemia.","volume":"90","author":"Al Kateb","year":"2002","journal-title":"Circ Res"},{"key":"R29-7-20210205","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2796.2003.01139.x","article-title":"A Q136Stop mutation in the ARH gene causing autosomal recessive hypercholesterolaemia with severely delayed LDL catabolism.","volume":"253","author":"Tietge","year":"2003","journal-title":"J Intern Med"},{"key":"R30-7-20210205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00041433-200304000-00002","article-title":"Molecular mechanisms of autosomal recessive hypercholesterolemia.","volume":"14","author":"Cohen","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"R31-7-20210205","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1210\/jcem.83.6.4840","article-title":"Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.","volume":"83","author":"Schmidt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-7-20210205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2004.01.020","article-title":"Autosomal recessive hypercholesterolaemia: long-term follow up and response to treatment.","volume":"174","author":"Naoumova","year":"2004","journal-title":"Atherosclerosis"},{"key":"R33-7-20210205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/hrt.76.1.84","article-title":"Aortic stenosis in homozygous familial hypercholesterolaemia.","volume":"76","author":"Rallidis","year":"1996","journal-title":"Heart"},{"key":"R34-7-20210205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/hrt.80.6.583","article-title":"Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia.","volume":"80","author":"Rallidis","year":"1998","journal-title":"Heart"},{"key":"R35-7-20210205","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/bmj.291.6502.1079","article-title":"Treatment of homozygous familial hypercholesterolaemia: an informative sibship.","volume":"291","author":"West","year":"1985","journal-title":"BMJ (Clin Res Ed)"},{"key":"R36-7-20210205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1526-0968.2003.00073.x","article-title":"Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia.","volume":"7","author":"Makino","year":"2003","journal-title":"Therap Apher Dial"},{"key":"R37-7-20210205","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/080352501750258793","article-title":"Low-density lipoprotein apheresis in a patient aged 3.5 years.","volume":"90","author":"Stefanutti","year":"2001","journal-title":"Acta Paediatr"},{"key":"R38-7-20210205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1526-0968.2003.00063.x","article-title":"Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its atherosclerotic vascular complications: dextran sulfate cellulose low-density lipoprotein apheresis.","volume":"7","author":"Keller","year":"2003","journal-title":"Therap Apher Dial"},{"key":"R39-7-20210205","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI200318925","article-title":"Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.","volume":"111","author":"Rader","year":"2003","journal-title":"J Clin Invest"},{"key":"R40-7-20210205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00251-4","article-title":"LDL apheresis.","volume":"167","author":"Thompson","year":"2003","journal-title":"Atherosclerosis"},{"key":"R41-7-20210205","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1526-0968.2003.00074.x","article-title":"Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia.","volume":"7","author":"Higashikata","year":"2003","journal-title":"Therap Apher Dial"},{"key":"R42-7-20210205","first-page":"1377","article-title":"Homozygous cutaneo-tendinous forms of hypercholesteremic xanthomatosis in an exemplary familial case. Trial of plasmapheresis and heroic treatment.","volume":"118","author":"de Gennes","year":"1967","journal-title":"Bull Mem Soc Med Hop Paris"},{"key":"R43-7-20210205","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(75)92193-5","article-title":"Plasma exchange in the management of homozygous familial hypercholesterolaemia.","volume":"1","author":"Thompson","year":"1975","journal-title":"Lancet"},{"key":"R44-7-20210205","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/hrt.43.6.680","article-title":"Assessment of long-term plasma exchange for familial hypercholesterolaemia.","volume":"43","author":"Thompson","year":"1980","journal-title":"Br Heart J"},{"key":"R45-7-20210205","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/bmj.291.6510.1671","article-title":"Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.","volume":"291","author":"Thompson","year":"1985","journal-title":"BMJ (Clin Res Ed)"},{"key":"R46-7-20210205","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(76)91736-0","article-title":"A new approach to the management of familial hypercholesterolaemia: removal of plasma-cholesterol based on the principle of affinity chromatography.","volume":"1","author":"Lupien","year":"1976","journal-title":"Lancet"},{"key":"R47-7-20210205","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(81)91213-7","article-title":"Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia.","volume":"2","author":"Stoffel","year":"1981","journal-title":"Lancet"},{"key":"R48-7-20210205","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/BF00212983","article-title":"Comparative long-term experience with immunoadsorption and dextran sulfate cellulose adsorption for extracorporeal elimination of low-density lipoproteins.","volume":"72","author":"Knisel","year":"1994","journal-title":"Clin Invest"},{"key":"R49-7-20210205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1365-2362.1996.2320587.x","article-title":"Prospective cross-over comparisons of three low-density lipoprotein (LDL)-apheresis methods in patients with familial hypercholesterolaemia.","volume":"26","author":"Schaumann","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"R50-7-20210205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1526-0968.1999.00154.x","article-title":"Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: a long-term evaluation.","volume":"3","author":"Richter","year":"1999","journal-title":"Ther Apher"},{"key":"R51-7-20210205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0021-9150(99)00398-6","article-title":"Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia.","volume":"151","author":"Schmaldienst","year":"2000","journal-title":"Atherosclerosis"},{"key":"R52-7-20210205","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1526-0968.2000.004005382.x","article-title":"Efficacy of different low-density lipoprotein apheresis methods.","volume":"4","author":"Parhofer","year":"2000","journal-title":"Ther Apher"},{"key":"R53-7-20210205","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1526-0968.2003.00070.x","article-title":"Low density lipoprotein apheresis: an overview.","volume":"7","author":"Bambauer","year":"2003","journal-title":"Ther Apher Dial"},{"key":"R54-7-20210205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00041433-199910000-00004","article-title":"Therapeutic effects of LDL apheresis in the prevention of atherosclerosis.","volume":"10","author":"Kajinami","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"R55-7-20210205","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1525-1594.2003.07200.x","article-title":"Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia.","volume":"27","author":"Otto","year":"2003","journal-title":"Artif Organs"},{"key":"R56-7-20210205","first-page":"61","article-title":"Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.","volume":"112","author":"Jansen","year":"2000","journal-title":"Wien Klin Wochenschr"},{"key":"R57-7-20210205","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-8703(97)70155-8","article-title":"Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia.","volume":"133","author":"Napoli","year":"1997","journal-title":"Am Heart J"},{"key":"R58-7-20210205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00001721-199909000-00004","article-title":"Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?","volume":"10","author":"Kizaki","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R59-7-20210205","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0735-1097(96)00388-9","article-title":"Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).","volume":"28","author":"Aengevaeren","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"R60-7-20210205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2362.1989.tb00192.x","article-title":"Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).","volume":"19","author":"Schuff-Werner","year":"1989","journal-title":"Eur J Clin Invest"},{"key":"R61-7-20210205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/039139880002300309","article-title":"Intraindividual comparison of the impact of two selective apheresis methods (DALI and HELP) on the coagulation system.","volume":"23","author":"Julius","year":"2000","journal-title":"Int J Artif Organs"},{"key":"R62-7-20210205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jca.10010","article-title":"The effects of three different LDL-apheresis methods on the plasma concentrations of E-selectin, VCAM-1, and ICAM-1.","volume":"17","author":"Empen","year":"2002","journal-title":"J Clin Apheresis"},{"key":"R63-7-20210205","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1526-0968.2003.00079.x","article-title":"The effect of apheresis on adhesion molecules.","volume":"7","author":"Motohashi","year":"2003","journal-title":"Therap Apher Dial"},{"key":"R64-7-20210205","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1526-0968.2003.00080.x","article-title":"Changes in C-reactive protein plasma levels during low-density lipoprotein apheresis.","volume":"7","author":"Kojima","year":"2003","journal-title":"Therap Apher Dial"},{"key":"R65-7-20210205","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1526-0968.2003.00076.x","article-title":"Low-density lipoprotein apheresis in the prevention of recurrent coronary heart disease: a review.","volume":"7","author":"Tasaki","year":"2003","journal-title":"Therap Apher Dial"},{"key":"R66-7-20210205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0021-9150(92)90026-D","article-title":"Effective reduction of plasma LDL levels by LDL apheresis in familial defective apolipoprotein B-100.","volume":"95","author":"Maher","year":"1992","journal-title":"Atherosclerosis"},{"key":"R67-7-20210205","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/01.ATV.12.9.1071","article-title":"Siblings with normal LDL receptor activity and severe hypercholesterolemia.","volume":"12","author":"Harada-Shiba","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"R68-7-20210205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S1047951102000240","article-title":"Impact of the characteristics of patients and their clinical management on outcomes in children with homozygous familial hypercholesterolemia.","volume":"12","author":"Al Shaikh","year":"2002","journal-title":"Cardiol Young"},{"key":"R69-7-20210205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0021-9150(80)90124-0","article-title":"Therapeutic effects of ML-236B in primary hypercholesterolemia.","volume":"35","author":"Yamamoto","year":"1980","journal-title":"Atherosclerosis"},{"key":"R70-7-20210205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0021-9150(99)00435-9","article-title":"Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia.","volume":"150","author":"Raal","year":"2000","journal-title":"Atherosclerosis"},{"key":"R71-7-20210205","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0022-2275(20)37137-6","article-title":"Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia.","volume":"38","author":"Marais","year":"1997","journal-title":"J Lipid Res"},{"key":"R72-7-20210205","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2165\/00003495-200262140-00008","article-title":"Rosuvastatin.","volume":"62","author":"Carswell","year":"2002","journal-title":"Drugs"},{"key":"R73-7-20210205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1567-5688(02)80435-4","article-title":"Effect of rosuvastatin on LDL-cholesterol, melavonic acid, and other lipid measurements in patients with homozygous familial hypercholesterolaemia. In: Posters and abstracts of the 73rd European Atherosclerosis Society Congress.","volume":"3","author":"Marais","year":"2002","journal-title":"Atherosclerosis Supplements"},{"key":"R74-7-20210205","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/01.CIR.0000018744.58460.62","article-title":"Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.","volume":"105","author":"Gagne","year":"2002","journal-title":"Circulation"},{"key":"R75-7-20210205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.atherosclerosis.2003.07.011","article-title":"Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia.","volume":"171","author":"Raal","year":"2003","journal-title":"Atherosclerosis"},{"key":"R76-7-20210205","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjp.0705187","article-title":"Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats.","volume":"138","author":"van Heek","year":"2003","journal-title":"Br J Pharmacol"},{"key":"R77-7-20210205","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1021\/jm960674d","article-title":"Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets.","volume":"39","author":"Lee","year":"1996","journal-title":"J Med Chem"},{"key":"R78-7-20210205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11883-002-0058-7","article-title":"Statins in homozygous familial hypercholesterolemia.","volume":"4","author":"Marais","year":"2002","journal-title":"Curr Atheroscler Rep"},{"key":"R79-7-20210205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/039139889501800210","article-title":"Treatment of homozygous and double heterozygous familial hypercholesterolemic children with LDL-apheresis.","volume":"18","author":"Stefanutti","year":"1995","journal-title":"Int J Artif Organs"},{"key":"R80-7-20210205","first-page":"756","article-title":"Pregnancy complicated by homozygous hypercholesterolemia.","volume":"65","author":"Barss","year":"1985","journal-title":"Obstet Gynecol"},{"key":"R81-7-20210205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9378(90)90824-Q","article-title":"Pregnancy in a homozygous familial hypercholesterolemic patient treated with long-term plasma exchange.","volume":"162","author":"Beigel","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R82-7-20210205","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/0026-0495(94)90061-2","article-title":"Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis.","volume":"43","author":"Kroon","year":"1994","journal-title":"Metabolism"},{"key":"R83-7-20210205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1526-0968.2003.00066.x","article-title":"Differential indication of lipoprotein apheresis during pregnancy.","volume":"7","author":"Klingel","year":"2003","journal-title":"Therap Apher Dial"},{"key":"R84-7-20210205","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0026-0495(95)90247-3","article-title":"Pregnancy in a patient with homozygous familial hypercholesterolemia undergoing low-density lipoprotein apheresis by dextran sulfate adsorption.","volume":"44","author":"Teruel","year":"1995","journal-title":"Metabolism"},{"key":"R85-7-20210205","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(84)91876-2","article-title":"Heart-liver transplantation in a patient with familial hypercholesterolaemia.","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet"},{"key":"R86-7-20210205","first-page":"807","article-title":"Normal levels of lipoproteins including lipoprotein(a) after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia.","volume":"85","author":"Barbir","year":"1992","journal-title":"Q J Med"},{"key":"R87-7-20210205","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-0012.2001.150612.x","article-title":"Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia.","volume":"15","author":"Offstad","year":"2001","journal-title":"Clin Transplant"},{"key":"R88-7-20210205","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1432-2277.2003.tb00299.x","article-title":"Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia.","volume":"16","author":"Shirahata","year":"2003","journal-title":"Transpl Int"},{"key":"R89-7-20210205","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/gast.2001.22583","article-title":"Liver transplantation: current status and novel approaches to liver replacement.","volume":"120","author":"Keeffe","year":"2001","journal-title":"Gastroenterology"},{"key":"R90-7-20210205","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1172\/JCI200113650","article-title":"Advances in hepatocyte transplantation: a myth becomes reality.","volume":"108","author":"Lee","year":"2001","journal-title":"J Clin Invest"},{"key":"R91-7-20210205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng0494-335","article-title":"Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia.","volume":"6","author":"Grossman","year":"1994","journal-title":"Nat Genet"},{"key":"R92-7-20210205","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/nm1195-1148","article-title":"A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia.","volume":"1","author":"Grossman","year":"1995","journal-title":"Nat Med"},{"issue":"Suppl 5","key":"R93-7-20210205","first-page":"40","article-title":"Gene therapy for familial hypercholesterolemia.","volume":"11","author":"Rader","year":"2001","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R94-7-20210205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00043798-199602000-00009","article-title":"The extracranial carotid artery in familial hypercholesterolaemia: relationship of intimal-medial thickness and plaque morphology with plasma lipids and coronary heart disease.","volume":"3","author":"Sidhu","year":"1996","journal-title":"J Cardiovasc Risk"},{"key":"R95-7-20210205","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/01.ATV.14.7.1066","article-title":"Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia.","volume":"14","author":"Hoeg","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"R96-7-20210205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1067\/mpd.2002.124384","article-title":"Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia.","volume":"141","author":"Jaeger","year":"2002","journal-title":"J Pediatr"},{"key":"R97-7-20210205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00004728-200105000-00008","article-title":"MR virtual angioscopy of thoracic aortic atherosclerosis in homozygous familial hypercholesterolemia.","volume":"25","author":"Summers","year":"2001","journal-title":"J Comput Assist Tomogr"},{"key":"R98-7-20210205","first-page":"588","article-title":"Fatal outcome of homozygous familial hypercholesterolaemia in a black patient: a case report.","volume":"77","author":"Marais","year":"1990","journal-title":"S Afr Med J"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003453-200447080-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:10:05Z","timestamp":1785784205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041433-200408000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mol.0000137222.23784.2a","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}